IceCure Medical Statistics

Total Valuation

ICCM has a market cap or net worth of $29.83 million. The enterprise value is $19.90 million.

Market Cap	29.83M
Enterprise Value	19.90M

Important Dates

The next confirmed earnings date is Tuesday, November 26, 2024, before market open.

Earnings Date	Nov 26, 2024
Ex-Dividend Date	n/a

Share Statistics

ICCM has 49.52 million shares outstanding. The number of shares has increased by 12.87% in one year.

Current Share Class	49.52M
Shares Outstanding	49.52M
Shares Change (YoY)	+12.87%
Shares Change (QoQ)	+4.77%
Owned by Insiders (%)	55.46%
Owned by Institutions (%)	0.45%
Float	22.06M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	8.44
Forward PS	6.88
PB Ratio	2.81
P/TBV Ratio	2.81
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	5.96
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.97, with a Debt / Equity ratio of 0.05.

Current Ratio	2.97
Quick Ratio	2.41
Debt / Equity	0.05
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -94.22% and return on invested capital (ROIC) is -59.72%.

Return on Equity (ROE)	-94.22%
Return on Assets (ROA)	-47.36%
Return on Capital (ROIC)	-59.72%
Revenue Per Employee	$43,325
Profits Per Employee	-$177,727
Employee Count	77
Asset Turnover	0.18
Inventory Turnover	0.84

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -18.58% in the last 52 weeks. The beta is 2.63, so ICCM's price volatility has been higher than the market average.

Beta (5Y)	2.63
52-Week Price Change	-18.58%
50-Day Moving Average	0.63
200-Day Moving Average	0.90
Relative Strength Index (RSI)	44.56
Average Volume (20 Days)	1,148,952

Short Selling Information

The latest short interest is 282,229, so 0.57% of the outstanding shares have been sold short.

Short Interest	282,229
Short Previous Month	287,665
Short % of Shares Out	0.57%
Short % of Float	1.28%
Short Ratio (days to cover)	0.46

Income Statement

In the last 12 months, ICCM had revenue of $3.34 million and -$13.69 million in losses. Loss per share was -$0.29.

Revenue	3.34M
Gross Profit	1.35M
Operating Income	-14.42M
Pretax Income	-14.49M
Net Income	-13.69M
EBITDA	-14.08M
EBIT	-14.42M
Loss Per Share	-$0.29

Full Income Statement

Balance Sheet

The company has $10.46 million in cash and $520,000 in debt, giving a net cash position of $9.94 million or $0.20 per share.

Cash & Cash Equivalents	10.46M
Total Debt	520,000
Net Cash	9.94M
Net Cash Per Share	$0.20
Equity (Book Value)	10.61M
Book Value Per Share	0.21
Working Capital	8.85M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$10.83 million and capital expenditures -$192,000, giving a free cash flow of -$11.02 million.

Operating Cash Flow	-10.83M
Capital Expenditures	-192,000
Free Cash Flow	-11.02M
FCF Per Share	-$0.22

Full Cash Flow Statement

Margins

Gross Margin	40.32%
Operating Margin	-432.13%
Pretax Margin	-410.22%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	-389.15%

Dividends & Yields

ICCM does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-12.87%
Shareholder Yield	-12.87%
Earnings Yield	-45.87%
FCF Yield	-36.94%

Analyst Forecast

The average price target for ICCM is $2.70, which is 348.13% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$2.70
Price Target Difference	348.13%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	94.44%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ICCM has an Altman Z-Score of -4.8 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-4.8
Piotroski F-Score	2